作者: M. Shayne Gallaway , Bin Huang , Quan Chen , Thomas C. Tucker , Jaclyn K. McDowell
DOI: 10.1007/S10900-019-00622-Z
关键词:
摘要: To examine smoking and use of cessation aids among tobacco-associated cancer (TAC) or non-tobacco-associated (nTAC) survivors. Understanding when if specific types resources are used can help with planning interventions to more effectively decrease all survivors, but there is a lack research on modalities Kentucky Cancer Registry data incident lung, colorectal, pancreatic, breast, ovarian, prostate cases diagnosed 2007–2011, were linked health administrative claims (Medicaid, Medicare, private insurers) the prevalence 1 year prior following diagnosis. TACs included lung cancers; nTAC cancers. There 10,033 TAC 13,670 Smoking before diagnosis was significantly higher survivors (p < 0.0001). Among persons who: males (83%), aged 45–64 unknown marital status (84%), had very low education (78%), public insurance (89%), Medicaid (85%) uninsured (84%). counseling pharmacotherapy common than (p < 0.01 p = 0.05, respectively). While reducing remains priority, given at increased risk for subsequent chronic diseases, including cancer. Tobacco (not just those TAC) improve prognosis, quality life reduce further disease. Health care providers recommend individual, group telephone and/or recommendations. These could also be in survivorship plans.